Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 100% —
Register , to see more distinctive signs of diseases and studies — 100%
liquorrhea
57%
—
benign neoplasms —
39%
convulsions
45%
—
thin dry skin —
36%
convulsive syndrome in children
42%
—
diffuse mastopathy —
34%
increased intracranial pressure
38%
—
leukoplakia —
34%
hernia
37%
—
fibrous mastopathy —
34%
hydrocephalus in children
37%
—
mastopathy —
34%
bone defects
36%
—
cystic mastopathy —
34%
brain development abnormalities
35%
—
uterine hypoplasia —
33%
pulsates
35%
—
cysts in the chest —
33%
microcephaly
33%
—
dyslalia —
33%
orbital hypertelorism
32%
—
ataxia in children —
33%
crying from pain
31%
—
chronic inflammation of the eyes —
31%
hypertension
30%
—
stopped menstruation —
30%
hemangioma
30%
—
amenorrhea —
28%
nose large eyes
28%
—
onset of illness —
28%
pain worse at immobility
28%
—
polycystic —
27%
hydrocephalus
28%
—
in the genus mental illness —
27%
nasal congestion
28%
—
sinusitis —
27%
polyps
27%
—
myopia —
27%
the pain is worse lying down
26%
—
inflammation of the tooth —
27%
cramps in the legs
26%
—
cystic fibrosis —
26%
head tumor
26%
—
oncology relatives —
26%
large child
25%
—
dry skin —
26%
mental retardation
25%
—
delay of mental development —
25%
cyanosis
25%
—
inflammation of the eyes —
25%
essential hypertension
24%
—
ataxia —
24%
cognitive disorders
24%
—
children's speech —
24%
brain tumor
24%
—
delayed speech development —
24%
scarring
23%
—
thyroid diseases —
24%
patient is motionless
23%
—
impaired coordination —
23%
a history of organ transplantation
23%
—
speech slurred —
23%
impaired venous function
22%
—
frequent colds —
23%
neurological disorders
21%
—
cysts —
22%
history of surgery
41%
18%
visual impairment —
22%
consequences of infection
20%
—
hormonal disorders —
21%
angioplasty
20%
—
dry —
21%
patient's condition
27%
18%
periodic illness —
20%
damage to the nervous system
29%
20%
heart dysfunction —
20%
diseases of the gastrointestinal tract —
20%
cancer —
20%
childhood diseases
20%
38%
oncology
19%
37%
inflammation —
18%
lags behind in the development
31%
37%
increased
18%
18%